Syrinx bioanalytics
WebBiopharma demand for bioanalysis is outstripping supply, according to Synexa Life Sciences, which says buying Syrinx Bioanalytics will help it capture a bigger share of the market. Biopharma ... WebMay 19, 2024 · Syrinx Bioanalytics is a bioanalytical service provider and CRO. It develops and validates methods and analyses biological samples for the determination of biomarkers and anti-drug antibodies in compliance with health authority requirements. Syrinx Bioanalytics was founded in 2007 and is based in Turku, Finland.
Syrinx bioanalytics
Did you know?
WebSYRINX Bioanalytics, part of the Synexa Life Sciences group, is a Contract Research Organization (CRO) offering a large variety of modern immunoassay techniques for the … Specialization makes SYRINX an ideal partner for pharmaceutical/biotech … Techniques. SYRINX offers a wide range of state-of-the-art assay techniques ideal … SYRINX laboratory, including an in house GLP archive, is in compliance to OECD … Contact us. SYRINX Bioanalytics PO Box 425 FI-20101 Turku Finland . Web: … About Syrinx Bioanalytics Founded in 2007, Syrinx Bioanalytics is a bioanalytical … SYRINX provides analytical services (in GMP) intended for the characterization or … SYRINX Bioanalytics has extensive experience of developing new methods … SYRINX offers a multi-step approach when performing immunogenicity testing. After … SYRINX is offering bioanalytics of biosimilars including PK, activity, binding … WebMar 3, 2024 · Synexa specialises in the development, validation and delivery of a wide range of complex and custom-designed assays, founded on deep expertise in immunology and the impact of the immune system on human health and candidate drug performance. Synexa is backed by Gilde Healthcare, a leading European healthcare investor.
WebSyrinx Bioanalytics Acquired by Synexa Life Sciences to Expand Scope of Bioanalysis. Jun 15, 2024. Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it has acquired Syrinx Bioanalytics, a bioanalytical CRO based in Turku, Finland. Image Credit: bogdanhoda/Shutterstock ...
WebFeb 9, 2024 · Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it has acquired Syrinx … WebBiomarkers. SYRINX offers a wide range of biomarker assays to support your drug development program. We can either offer you an already established bioanalytical method or we can set up an assay for your specific needs (matrix, species, etc.). All assays can be validated according to GLP (please enquire for validation status).
WebBioAnalytics USA n/a BioAnalytics is an early-stage biotechnology company focused on designing the next generation of immunoassay technology. BioAnalytics has developed a novel technique which reduces immunoassay complexity and cross reactivity in order to provide tests with the potential for faster turnaround times, less variability, higher ...
WebSYRINX Bioanalytics, part of the Synexa Life Sciences group, is a CRO focusing on the bioanalysis and immunogenicity testing of biological drugs, vaccines and biomarkers using state-of-the-art immunological and cell based methods as well as on SPR and RIA analysis of small molecules. raymond james fixed income conferenceWebBioAnalytics is an early-stage biotechnology company focused on designing the next generation of immunoassay technology. BioAnalytics concentrates on improving test speed, sensitivity, and... raymond james fitness clubWebMay 24, 2024 · 24 May 2024 Science. Synexa Life Sciences BV, a global leader in specialist biomarker and bioanalysis research services, has today announced that it has acquired Syrinx Bioanalytics, a bioanalytical CRO based in Turku, Finland. The move is part of Synexa’s ongoing ‘buy and build’ growth strategy, aimed at building a global market leader ... raymond james fixed income capital marketsWebSyrinx is particularly strong in PK/immunogenicity testing of regulated bioanalysis, while Synexa’s core strengths lie in its broad portfolio of specialist biomarker and bioanalytical assays, spanning DNA, RNA, protein, cell and tissue capabilities. raymond james fiscal year endWebSyrinx Bioanalytics is a CRO that focuses on the bioanalysis and immunogenicity testing of biological drugs, vaccines and biomarkers. Acquired by Synexa Life Sciences Turku, … raymond james first financial bankWebJun 15, 2024 · Syrinx is particularly strong in PK/immunogenicity bioanalysis, while Synexa’s core strengths lie in its broad portfolio of specialist biomarker and bioanalytical assays, spanning DNA, RNA,... raymond james fixed income weeklyWebSYRINX Bioanalytics is a CRO providing GLP compliant laboratory services using state-of-the-art immunological and cell based methods. Our main services are PK sample analysis, … raymond james fixed income weekly primer